Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 23, 2013
USPLabs Settles Class Action Lawsuit Over Controversial DMAA Ingredient
Once thought to be a natural component of geranium oil, the DMAA found in supplements is now thought to be synthetic, and has been found to cause harmful side effects such as increasing blood pressure and the risk cardiovascular events.
USPLabs denied that any of the claims made in the lawsuit were true and maintained that the settlement “does not mean that any law was broken,” but did agree to pay up to $2 million in reimbursements to consumers who purchased the products between January 1, 2012 and August 17, 2012. The company also agreed to make the warning statements on the supplement labels larger and easier to understand.
Manufacturers and distributors of supplements containing DMAA, including USPLabs, were warned by the FDA in April 2012 not to sell products containing the ingredient. At that time the agency had received 42 reports of adverse events associated with supplements containing DMAA. Another FDA warning was issued to a manufacturer of a weight loss supplement containing DMAA in August 2012.
In 2011, weight loss and bodybuilding supplements containing DMAA were linked to the deaths of two U.S. military soldiers.
OxyELITEPRO, promoted for weight loss, contained DMAA, Bauhinia purpurea, Bacopa monniera, Cirsium oligophyllum, and Rauwolscine canescens.
Promoted for boosting energy and enhancing muscle, Jacked3d also contained DMAA, along with arginine, creatine, beta-alanine, caffeine and Schisandra chinensis. USPLabs released a reformulated version of Jacked3d that does not contain DMAA, called Jacked3d Micro.
Consumers who purchased OxyELITEPRO or Jacked3d and want to learn more about making a settlement claim can visit the official USPLabs Settlement website.
To read the complete settlement agreement, use the link below.